Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons
- 1 April 2003
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (7) , 2564-2571
- https://doi.org/10.1523/jneurosci.23-07-02564.2003
Abstract
α-Synuclein is a presynaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease. The native protein is a major component of nigral Lewy bodies in Parkinson's disease, and full-length α-synuclein accumulates in Lewy neurites. Here we present evidence that α-synuclein levels are elevated in midbrain dopamine (DA) neurons of chronic cocaine abusers. Western blot and immunoautoradiographic studies were conducted on postmortem neuropathological specimens from cocaine users and age-matched drug-free control subjects. The results demonstrated that α-synuclein levels in the DA cell groups of the substantia nigra/ventral tegmental complex were elevated threefold in chronic cocaine users compared with normal age-matched subjects. The increased protein levels in chronic cocaine users were accompanied by changes in the expression of α-synuclein mRNA in the substantia nigra and ventral tegmental area. Although α-synuclein expression is prominent in the hippocampus, there was no increase in protein expression in this brain region. The levels of β-synuclein, a possible negative regulator of α-synuclein, also were not affected by cocaine exposure. α-Synuclein protein levels were increased in the ventral tegmental area, but not the substantia nigra, in victims of excited cocaine delirium who experienced paranoia, marked agitation, and hyperthermia before death. The overexpression of α-synuclein may occur as a protective response to changes in DA turnover and increased oxidative stress resulting from cocaine abuse. However, the accumulation of α-synuclein protein with long-term cocaine abuse may put addicts at increased risk for developing the motor abnormalities of Parkinson's disease.Keywords
This publication has 58 references indexed in Scilit:
- Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative DisordersScience, 2000
- Expression of ?-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's diseaseAnnals of Neurology, 2000
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Self‐oligomerization of NACP, the precursor protein of the non‐amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C‐terminal Aβ fragment (residues 25–35)FEBS Letters, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Characterization of a novel protein regulated during the critical period for song learning in the zebra finchPublished by Elsevier ,1995
- Differing Neurotoxic Potencies of Methamphetamine, Mazindol, and Cocaine in Mesencephalic CulturesJournal of Neurochemistry, 1993
- Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brainNeurochemical Pathology, 1985